Piramal Pharma financial results announcements

Financial ResultsPiramal Pharma Ltd PPLPHARMA

Piramal Pharma Q2 FY27 Results: Turns Profitable, Net Profit ₹5 Cr

Piramal Pharma Ltd reported revenue from operations of ₹2,617 Cr (+28.1% YoY) and net profit of ₹5 Cr for Q2 FY27.

Key figure

Net profit ₹5 Cr

Financial ResultsPiramal Pharma Ltd PPLPHARMA

Piramal Pharma Q1 FY27 Results: Net Loss of ₹69.4 Cr, Loss Narrows

Piramal Pharma Ltd reported revenue from operations of ₹2,270 Cr (+17.4% YoY) and a net loss of ₹69.4 Cr for Q1 FY27.

Key figure

Net loss ₹69.4 Cr

Financial ResultsPiramal Pharma Ltd PPLPHARMA

Piramal Pharma Q4 FY26 Results: Net Loss of ₹8.8 Cr

Piramal Pharma Ltd reported revenue from operations of ₹2,752 Cr (-0.1% YoY) and a net loss of ₹8.8 Cr for Q4 FY26.

Key figure

Net loss ₹8.8 Cr

Financial ResultsPiramal Pharma Ltd PPLPHARMA

Piramal Pharma Financial Results

Piramal Pharma Limited reported its FY2026 audited financial results, showing standalone annual revenue of ₹4,782.01 Crore and PAT of ₹700.01 Crore. The Board also approved the re-appointment of Ms. Nandini Piramal as Chairperson and Mr. Peter DeYoung as Executive Director, alongside shifting the company's registered office and appointing a new Company Secretary.